April 20, 2018 / 7:41 PM / 5 months ago

BRIEF-Alexion Says No Compulsory License Of Soliris Was Requested Or Granted In Brazil

April 20 (Reuters) - Alexion Pharmaceuticals Inc:

* ALEXION PROVIDES STATEMENT ON SUPERIOR COURT OF JUSTICE (STJ) DECISION IN BRAZIL INVOLVING SOLIRIS® (ECULIZUMAB)

* ALEXION PHARMACEUTICALS - ALEXION WOULD LIKE TO CLARIFY THAT NO COMPULSORY LICENSE OF SOLIRIS WAS REQUESTED OR GRANTED IN BRAZIL

* ALEXION PHARMACEUTICALS INC - CONTINUES TO HAVE PATENT APPLICATIONS PENDING IN BRAZIL THAT WOULD PROVIDE ADDITIONAL PROTECTION TO SOLIRIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below